Why is left ventricular hypertrophy so predictive of morbidity and mortality?

American Journal of the Medical Sciences

Volumn 317, Issue 3, 1999, Pages 168-175

  Benjamin, Emelia J ^a,d   Levy, Daniel ^a,b,c  

^a BOSTON MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d FRAMINGHAM HEART STUDY   (United States)

Author keywords

African American; Cohort studies; Echocardiography; Left ventricular hypertrophy; Prognosis

Indexed keywords

CARDIOVASCULAR RISK; CONFERENCE PAPER; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MORBIDITY; MORTALITY; PREVALENCE; PROGNOSIS; RISK FACTOR;

EID: 0033505795     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9629(15)40499-9     Document Type: Conference Paper

References (79)

1. Levy D, Labib SB, Anderson KM, et al. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation 1990;81:815-20.
2. Xie X, Liu K, Stamler J, et al. Ethnic differences in electrocardiographic left ventricular hypertrophy in young and middle-aged employed American men. Am J Cardiol 1994:73-564-7.
3. Gottdiener J, Reda DJ, Materson BJ, et al. Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. J Am Coll Cardiol 1994;24:1492-8.
4. Arnett DK, Rautaharju P, Crow R, et al. Black-white differences in electrocardiographic left ventricular mass and its association with blood pressure (the ARIC study). Atherosclerosis Risk in Communities. Am J Cardiol 1994;74:247-52.
5. Gardin JM, Wagenknecht LE, Anton-Culver H, et al. Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women. The CARDIA study. Coronary Artery Risk Development in Young Adults. Circulation 1995; 92:380-7.
6. Liebson PR, Grandits G, Prineas R, et al. Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation 1993;87: 476-86.
7. Chaturvedi N, Athanassopoulos G, McKeigue PM, et al. Echocardiographic measures of left ventricular structure and their relation with rest and ambulatory blood pressure in blacks and whites in the United Kingdom. J Am Coll Cardiol 1994;24:1499-1505.
8. Hinderliter AL, Light KC, Willis PWI. Racial differences in left ventricular structure in healthy young adults. Am J Cardiol 1992;69:1196-9.
9. Zabalgoitia M, Rahman SNU, Haley WE, et al. Impact of ethnicity on left ventricular mass and relative wall thickness in essential hypertension. Am J Cardiol 1998;81:412-7.
10. Kannel WB, Dawber TR, Kagan A, et al. Factors of risk in the development of coronary heart disease - six-year follow-up experience: The Framingham Study. Ann Intern Med 1961;55:33-50.
11. Kannel WB, Gordon T, Castelli WP, et al. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. Ann Intern Med 1970; 72:813-22.
12. Kannel WB. Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Med 1983;75:4-11.
13. Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993;22:6A-13A.
14. Kahn S, Frishman WH, Weissman S, et al. Left ventricular hypertrophy on electrocardiogram: prognostic implications from a 10-year cohort study of older subjects: a report from the Bronx Longitudinal Aging Study. J Am Geriatr Soc 1996;44:524-9.
15. Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-6.
16. Bikkina M, Levy D, Evans JC, et al. Left ventricular mass and risk of stroke in an elderly cohort. The Framingham Heart Study. JAMA 1994;272:33-6.
17. Ghali JK, Liao Y, Simmons B, et al. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med 1992;117:831-6.
18. Liao Y, Cooper RS, McGee DL, et al. The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. JAMA 1995;273:1592-7.
19. Liao Y, Cooper RS, Mensah GA, et al. Left ventricular hypertrophy has a greater impact on survival in women than in men. Circulation 1995;92:805-10.
20. Casale PN, Devereux RB, Milner M, et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986;105:173-8.
21. Koren MJ, Devereux RB, Casale PN, et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114:345-52.
22. Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol 1995;25:879-84.
23. Verdecchia P, Schillaci G, Borgioni C, et al. Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy. Am J Cardiol 1996;78:197-202.
24. Levy D, Anderson KM, Savage DD, et al. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med 1988;108:7-13.
25. Manolio TA, Levy D, Garrison RJ, et al. Relation of alcohol intake to left ventricular mass: The Framingham Study. J Am Coll Cardiol 1991;17:717-21.
26. Lauer MS, Anderson KM, Levy D. Influence of contemporary versus 30-year blood pressure levels on left ventricular mass and geometry: the Framingham Heart Study. J Am Coll Cardiol 1991;18:1287-94.
27. Gardin JM, Arnold A, Gottdiener J, et al. Left ventricular mass in the elderly. The Cardiovascular Health Study. Hypertension 1997;29:1095-103.
28. Devereux RB, Roman MJ, de Simone G, et al. Relations of left ventricular mass to demographic and hemodynamic variables in American Indians: the Strong Heart Study. Circulation 1997;96:1416-23.
29. Lee M, Gardin JM, Lynch JC, et al. Diabetes mellitus and echocardiographic left ventricular function in free-living elderly men and women: The Cardiovascular Health Study Am Heart J 1997;133:36-43.
30. Devereux RB, Savage DD, Sachs I, et al. Relation of hemodynamic load to left ventricular hypertrophy and performance in hypertension. Am J Cardiol 1983;51:171-6.
31. Liao Y, Cooper RS, Durazo-Arvizu R, et al. Prediction of mortality risk by different methods of indexation for left ventricular mass. J Am Coll Cardiol 1997;29:641-7.
32. Gardin JM, Siscovick D, Anton-Culver H, et al. Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. The Cardiovascular Health Study. Circulation 1995;91:1739-48.
33. Dannenberg AL, Levy D, Garrison RJ. Impact of age on echocardiographic left ventricular mass in a healthy population (the Framingham Study). Am J Cardiol 1989;64:1066-8.
34. Vasan RS, Larson M, Levy D, et al. Distribution and categorization of echocardiographic measurements in relation to reference limits: the Framingham Heart Study: formulation of a height-and sex-specific classification and its prospective validation. Circulation 1997;96:1863-73.
35. Levy D, Lauer MS. Left ventricular hypertrophy: Echocardiographic assessment and prognostic implications, in Sutton MSJ, editor. Textbook of adult and pediatric echocardiography and Doppler. Boston: Blackwell Scientific Publications; 1997. p. 342-52.
36. Post WS, Larson MG, Myers RH, et al. Heritability of left ventricular mass: the Framingham Heart Study. Hypertension 1997;30:1025-8.
37. Lauer MS, Anderson KM, Levy D. Separate and joint influences of obesity and mild hypertension on left ventricular mass and geometry: the Framingham Heart Study. J Am Coll Cardiol 1992;19:130-4.
38. Post WS, Larson MG, Levy D. Impact of left ventricular structure on the incidence of hypertension. The Framingham Heart Study. Circulation 1994;90:179-85.
39. de Simone G, Devereux RB, Roman MJ, et al. Echocardiographic left ventricular mass and electrolyte intake predict arterial hypertension. Ann Intern Med 1991;114:202-9.
40. Iso H, Kiyama M, Doi M, et al. Left ventricular mass and subsequent blood pressure changes among middle-aged men in rural and urban Japanese populations. Circulation 1994; 89:1717-24.
41. Lauer MS, Anderson KM, Kannel WB, et al. The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA 1991;266:231-6.
42. Roman MJ. How best to identify prognostically important left ventricular hypertrophy: a cut to the chase. J Am Coll Cardiol 1997;29:648-50.
43. Galderisi M, Anderson KM, Wilson PWF, et al. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol 1991;68:85-9.
44. Sasson Z, Rasooly Y, Bhesania T, et al. Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation 1993;88(4 Pt 1):1431-6.
45. Devereux RB, Drayer JIM, Chien S, et al. Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension. Am J Cardiol 1984;54:592-5.
46. Savage DD, Levy D, Dannenberg AL, et al. Association of echocardiographic left ventricular mass with body size, blood pressure, and physical activity (the Framingham Study). Am J Cardiol 1990;65:371-6.
47. Pelliccia A, Maron BJ, Spataro A, et al. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med 1991;324:295-301.
48. Harshfield GA, Grim CE, Hwang C, et al. Genetic and environmental influences on echocardiographically determined left ventricular mass in black twins. Am J Hypertens 1990;3:538-43.
49. Radice M, Alli C, Avanzini F, et al. Left ventricular structure and function in normotensive adolescents with a genetic predisposition to hypertension. Am Heart J 1986;111:115-20.
50. Verhaaren HA, Schicken RM, Mosteller M, et al. Bivariate genetic analysis of left ventricular mass and weight in pubertal twins (The Medical College of Virginia Twin Study). Am J Cardiol 1991;68:661-8.
51. Devereux RB, Roman MJ. Hypertensive cardiac hypertrophy: pathophysiologic and clinical characteristics, in Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis, and management. New York: Raven Press; 1995. p. 409-432.
52. Frohlich ED. Potential mechanisms explaining the risk of left ventricular hypertrophy. Am J Cardiol 1987;59: 91A-97A.
53. Cupples LA, Gagnon DR, Kannel WB. Long and short-term risk of sudden coronary death. Circulation 1992;85(1 Suppl):I11-I18.
54. McLenachan JM, Henderson E, Morris KI, et al. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med 1987;317:787-92.
55. Messerli FH, Ventura HO, Elizardi DJ, et al. Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med 1984;77:18-22.
56. Levy D, Anderson KM, Savage DD, et al. Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987;60:560-5.
57. Bikkina M, Larson MG, Levy D. Asymptomatic ventricular arrhythmias and mortality risk in subjects with left ventricular hypertrophy. J Am Coll Cardiol 1993;22:1111-6.
58. Rials SJ, Wu Y, Xu X, et al. Regression of left ventricular hypertrophy with captopril restores normal ventricular action potential duration, dispersion of refractoriness, and vulnerability to inducible ventricular fibrillation. Circulation 1997;96:1330-6.
59. Levy D, Garrison RJ, Savage DD, et al. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. Ann Intern Med 1989; 110:101-7.
60. Bolognese L, Dellavesa P, Rossi L, et al. Prognostic value of left ventricular mass in uncomplicated acute myocardial infarction and one-vessel coronary artery disease. Am J Cardiol 1994;73:1-5.
61. Dellsperger KC, Marcus ML. Effects of left ventricular hypertrophy on the coronary circulation. Am J Cardiol 1990; 65:1504-10.
62. Houghton JL, Frank MJ, Carr AA, et al. Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease. J Am Coll Cardiol 1990;15:43-51.
63. Houghton JL, Smith VE, Strogatz DS, et al. Effect of African-American race and hypertensive left ventricular hypertrophy on coronary vascular reactivity and endothelial function. Hypertension 1997;29:706-14.
64. Choudhury L, Rosen SD, Patel D, et al. Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy: a study with positron emission tomography. Eur Heart J 1997;18:108-16.
65. Fujita M, Mikuniya A, McKown DP, et al. Regional myocardial volume alterations induced by brief repeated coronary occlusion in conscious dogs. J Am Coll Cardiol 1988;12:1048-53.
66. Koyanagi S, Eastham CL, Harrison DG, et al. Increased size of myocardial infarction in dogs with chronic hypertension and left ventricular hypertrophy. Circ Res 1982;50:55-62.
67. Devereux RB, Alderman MH. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events. Circulation 1993;88(4 Pt 1): 1444-55.
68. Roman MJ, Saba PS, Pini R, et al. Parallel cardiac and vascular adaptation in hypertension. Circulation 1992;86: 1909-18.
69. Okin PM, Devereux RB, Kligfield P. Association of carotid atherosclerosis with electrocardiographic myocardial ischemia and left ventricular hypertrophy. Hypertension 1996; 28:3-7.
70. Kronmal RA, Smith VE, O'Leary DH, et al. Carotid artery measures are strongly associated with left ventricular mass in older adults (a report from the Cardiovascular Health Study). Am J Cardiol 1996;77:628-33.
71. Sheps SG, Frohlich ED. Limited echocardiography for hypertensive left ventricular hypertrophy. Hypertension 1997; 29:560-3.
72. MacMahon SW, Wilcken DEL, Macdonald GJ. The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients. N Engl J Med 1986;314:334-9.
73. Schmieder RE, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension. A metaanalysis of randomized double-blind studies. JAMA 1996; 275:1507-13.
74. Levy D, Salomon M, D'Agostino RB, et al. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 1994;90:1786-93.
75. Muiesan ML, Salvetti M, Rizzoni D, et al. Persistence of left ventricular hypertrophy is a stronger indicator of cardiovascular events than baseline left ventricular mass or systolic performance: 10 years of follow-up. J Hypertens 1996;14: S43-9
76. Yurenev AP, Dyakonova HG, Novikov ID, et al. Management of essential hypertension in patients with different degrees of left ventricular hypertrophy. Multicenter trial. Am J Hypertens 1992;5(6 Pt 2):182S-9S
77. Verdecchia P, Schillaci G, Borgioni C, et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998;97:48-54.
78. Devereux RB, Agabiti-Rosei E, Dahlof B, et al. Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials. J Hypertens Suppl 1996;14(2):S95-101.
79. Ghali JK, Liao Y, Cooper RS. Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease. J Am Coll Cardiol 1998;31:1635-1640.